Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Abstract

SummaryBackgroundA key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016.MethodsDrawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita.FindingsIn 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China,...

Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017

“…5 China and Turkey have some of the fastest improvements in the Healthcare Access and Quality Index, a composite metric of amenable mortality. 18 This improvement in preventing amenable causes of death suggests that the healthcare systems in these countries have improved and are likely to have contributed to the rapid declines in LRI mortality. Access to care, adherence to treatment protocols, maternal education, appropriate technology, and adequate healthcare staffing have all been identified as predictors of under5 LRI survival 5 that were not quantified in this study and might be components of a comprehensive LRI treatment strategy.…”

The carbon footprint of the Chinese health-care system: an environmentally extended input–output and structural path analysis study

“…30 However, in terms of the Healthcare Access and Quality index, the health-care service of China, which scored 78, performed worse than those of developed countries (89 in the USA to 96 in Australia). 31 Additionally, China has greater GHG emissions attributable to pharma ceuticals as a proportion of the health care carbon footprint. The main reason for this is the large proportion of health expenditure on pharmaceuticals, which is related to drug pricing and lower staff salaries than in more developed countries.…”

Internationally lost COVID-19 cases

“…The HAQ Index of 25 countries with confirmed COVID-19 cases reported by the WHO was sourced from a previously published study by the GBD 2016 Healthcare Access and Quality Collaborators [4].…”